FIELD: pharmaceuticals.
SUBSTANCE: claimed group of inventions relates to pharmaceutical composition intended to provide an agent for induced hypometabolism and hypothermia in mammals. Pharmaceutical composition includes a beta-blocker propranolol, sympatholitic reserpine, an antianginal drug ivabradine, an antihistamine drug diphenhydramine, serotonin hydrochloride, neuroleptic agent with hypothermic effect of pericyazine, antithyroid agent propicil, magnesium sulfate and pharmaceutically acceptable solvent, in the amounts indicated in the claims.
EFFECT: invention provides use of a new agent in emergency medicine.
3 cl, 1 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS INCLUDING PERFLUORIDECARBON EMULSION (VARIANTS), ITS USE AND METHOD OF CREATING REVERSIBLE PHARMACOLOGICALLY INDUCED HYPOMETABOLISM AND HYPOTHERMIA | 2017 |
|
RU2669398C1 |
| MEANS INCLUDING FAT EMULSION (VARIANTS), ITS USE AND METHOD OF CREATING REVERSIBLE PHARMACOLOGICALLY INDUCED HYPOMETABOLISM AND HYPOTHERMIA | 2017 |
|
RU2668374C1 |
| AGENT INCLUDING CYCLIC GLUCOSE OLIGOMER (OPTIONS), ITS APPLICATION AND METHOD OF CREATING REVERSIBLE PHARMACOLOGICALLY INDUCED HYPOMETABOLISM AND HYPOTHERMIA | 2017 |
|
RU2669399C1 |
| MEANS COMPRISING A FAT EMULSION (VARIANTS), ITS USE AND A METHOD FOR INCREASING THE RESISTANCE OF A MAMMALIAN ORGANISM TO SUPERCOOLING | 2017 |
|
RU2668375C1 |
| METHOD OF INHIBITING TUMOUR GROWTH IN MAMMAL | 2018 |
|
RU2713153C1 |
| AGENT COMPRISING A PERFLUOROCARBON EMULSION (OPTIONS), ITS APPLICATION AND METHOD FOR IMPROVING RESISTANCE OF MAMMAL ORGANISM TO SUPERCOOLING | 2017 |
|
RU2665964C1 |
| AGENT, ITS APPLICATION AND METHOD FOR IMPROVING RESISTANCE OF MAMMAL ORGANISM TO SUPERCOOLING | 2017 |
|
RU2665963C1 |
| USE OF XENON IMMOBILIZED IN CARRIER IN AGENT FOR INCREASING BODY RESISTANCE TO HYPOXIA | 2018 |
|
RU2696100C1 |
| NOVEL ISOPULEGOL-BASED AGENTS INDUCING HYPOTHERMIA IN ANIMALS | 2023 |
|
RU2814731C1 |
| ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
